CA
PHVS icon

CoreCap Advisors’s Pharvaris PHVS Stock Holding History

CoreCap Advisors’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.4K Buy
+2,700
New +$81.7K ﹤0.01% 1138

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

CoreCap Advisors's PHVS Position: Q2 2026 in Review

CoreCap Advisors opened a new position in Pharvaris (PHVS) in Q2 2026: 2,700 shares worth $93.4K. The stake represents ﹤0.01% of the portfolio and ranks #1138 among its holdings.

125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • CoreCap Advisors held 2,700 shares of Pharvaris worth $93.4K as of Q2 2026.
  • Pharvaris was a new CoreCap Advisors position in Q2 2026.
  • Pharvaris made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1138 holding.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.